🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT06638515
Recruiting Not applicable

Effects of Walking Apnea At Low Lung Volume on Hypoalgesia

NCT06638515 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2024-11-01
Last updated
2024-10-15

Condition(s) studied

PainHypoxemiaHypercapniaApneas

Investigational drug(s) / intervention(s)

Walking apnea at Low Lung VolumeWalking at normal breathing

Walking apnea at Low Lung Volume: Walking apnea at low Lung Volume Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes. Participants in the experimental group will perform intermittent apneas at high lung volume with a density of 5 seconds, followed by a normal breath of 5 seconds until completing the 6 minutes)

Walking at normal breathing: Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes. Participants in the control group will remain breathing normally for these 6 minutes.

Study summary

The aim of this randomized controlled study is to explore the hypoalgesic response of a 6 minutes of intermittent walking apneas training session at low lung volume in healthy subjects; also, as secondary objectives, to analyze the cardiovascular and respiratory response produced during the intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Asymptomatic subjects aged between 18 and 64 years. Exclusion Criteria: * Cardiovascular, respiratory, metabolic, neurological or osteomuscular signs or pathologies. * History of epilepsy. * Pregnant * Pharmacological treatment. * Participants who present any type of pain on the day of the measurements or who have frequently suffered pain during the previous 4 weeks.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CSEU LaSalle Madrid Spain Recruiting

More Universidad Rey Juan Carlos trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06638515 on ClinicalTrials.gov ↗ ← All trials in Spain